Breaking News - The Fly

Open Search

HALO

Halozyme

$

()

Halozyme initiated with bullish view at TD Cowen, here's why

HALO

2/29/2024 - 05:41am

Halozyme price target raised by $2 at H.C. Wainwright, here's why

HALO

2/21/2024 - 06:09am

Halozyme sees FY24 royalty revenue $500M-$525M

HALO

2/20/2024 - 16:10pm

Halozyme announces new $750M share repurchase plan

HALO

2/20/2024 - 16:03pm

Halozyme backs FY24 adjusted EPS view $3.55-$3.90, consensus $3.51

HALO

2/20/2024 - 16:03pm

Halozyme reports Q4 adjusted EPS 82c, consensus 82c

HALO

2/20/2024 - 16:02pm

Halozyme announces Takeda received EC approval for HYQVIA

HALO , TAK

1/29/2024 - 16:30pm

Halozyme announces approval for Vydura in Japan

HALO

1/18/2024 - 08:33am

Halozyme price target lowered by $13 at H.C. Wainwright, here's why

HALO

1/18/2024 - 06:14am

Halozyme: Takeda receives FDA approval of HYQVIA co-formulated with ENHANZE

HALO , TAK

1/16/2024 - 08:17am

Halozyme announces Roche receives EC marketing authorization of Tecentriq SC

HALO , RHHBY

1/16/2024 - 05:59am

Halozyme price target lowered by $2 at Morgan Stanley, here's why

HALO , ARGX

12/26/2023 - 07:46am

Halozyme price target lowered to $45 from $46 at Goldman Sachs

HALO , ARGX

12/20/2023 - 17:24pm

Halozyme's Vyvgart SC receives European Commission approval

HALO

11/16/2023 - 09:04am

Halozyme price target lowered to $46 from $48 at Piper Sandler

HALO

11/7/2023 - 07:35am